{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:09:20Z","timestamp":1776704960093,"version":"3.51.2"},"reference-count":90,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Colorectal cancer (CRC) is the third most common cancer worldwide. There is a need for the early diagnosis of CRC for a better prognostic outcome. It is, therefore, crucial to understand the CRC pathogenesis in all its aspects. In many cases, one of the main causes of cancer-related deaths is the presence of metastases. In this context, an often overlooked aspect is the metastatic tropism, since CRC, like other cancers, is more prone to metastasize some organs rather than others. Beyond the liver and lung, and differently from other types of cancers, a not usual site of CRC metastases is the bone. However, it may assume a crucial role in the development and the outcome of the disease. Therefore, this review aims to discuss the complex relations between bone markers and CRC pathogenesis, suggesting the use of these molecules as potential targets for therapeutic purposes. Different osteogenic molecules, some of whom are growth factors and are implicated in the different osteogenic pathways, have been proved to also be involved in CRC progression. Some of them are oncogenes, while others oncosuppressors, and in a future perspective, some of them may represent new potential CRC biomarkers.<\/jats:p>","DOI":"10.3390\/cancers12082029","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T09:06:09Z","timestamp":1595581569000},"page":"2029","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Colorectal Cancer and Bone Tissue: Fantastic Relations and Where to Find Them"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3712-4149","authenticated-orcid":false,"given":"Isabella","family":"Gigante","sequence":"first","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology \u201cS. de Bellis\u201d Research Hospital, 70013 Castellana Grotte, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7395-8584","authenticated-orcid":false,"given":"Valeria","family":"Tutino","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology \u201cS. de Bellis\u201d Research Hospital, 70013 Castellana Grotte, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"De Nunzio","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology \u201cS. de Bellis\u201d Research Hospital, 70013 Castellana Grotte, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-2198","authenticated-orcid":false,"given":"Maria","family":"Notarnicola","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology \u201cS. de Bellis\u201d Research Hospital, 70013 Castellana Grotte, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"ref_1","first-page":"83","article-title":"Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry","volume":"28","author":"Ahmadi","year":"2014","journal-title":"Med. J. Islamic Repub. Iran"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-13-0780","article-title":"Associations between cigarette smoking, hormone therapy, and folate intake with incident colorectal cancer by TP53 protein expression level in a population-based cohort of older women","volume":"23","author":"Tillmans","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/bmj.321.7265.886","article-title":"ABC of colorectal cancer. Molecular basis for risk factors","volume":"321","author":"Hardy","year":"2000","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","article-title":"Lessons from hereditary colorectal cancer","volume":"87","author":"Kinzler","year":"1996","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mrfmmm.2010.04.002","article-title":"High-throughput SNP\/CGH approaches for the analysis of genomic instability in colorectal cancer","volume":"693","author":"Brenner","year":"2010","journal-title":"Mutat. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: The \u2018seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1699-0463.1993.tb00109.x","article-title":"Epithelium-mesenchyme interconversion as example of epithelial plasticity","volume":"101","author":"Boyer","year":"1993","journal-title":"Acta Pathol. Microbiol. Immunol. Scand."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"ref_9","first-page":"361","article-title":"Tropism of cancer stem cells to a specific distant organ","volume":"28","author":"Okuda","year":"2014","journal-title":"In Vivo"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.cr.7310118","article-title":"Beyond tumorigenesis: Cancer stem cells in metastasis","volume":"17","author":"Li","year":"2007","journal-title":"Cell Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/carcin\/bgh293","article-title":"Will cancer stem cells provide new therapeutic targets?","volume":"26","author":"Behbod","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Itatani, Y., Kawada, K., Inamoto, S., Yamamoto, T., Ogawa, R., Taketo, M.M., and Sakai, Y. (2016). The Role of Chemokines in Promoting Colorectal Cancer Invasion\/Metastasis. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050643"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3816\/CCC.2005.n.022","article-title":"Changing patterns of bone and brain metastases in patients with colorectal cancer","volume":"5","author":"Sundermeyer","year":"2005","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clcc.2012.06.004","article-title":"Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: Results from South Australian clinical registry for advanced colorectal cancer","volume":"11","author":"Khattak","year":"2012","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/DCR.0000000000001071","article-title":"Characteristics and Prognostic Factors of Bone Metastasis in Patients With Colorectal Cancer","volume":"61","author":"Kawamura","year":"2018","journal-title":"Dis. Colon Rectum"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0973-1482.181177","article-title":"Colorectal cancer presenting as bone metastasis","volume":"13","author":"Babu","year":"2017","journal-title":"J. Cancer Res. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/annonc\/mdr572","article-title":"Natural history of bone metastasis in colorectal cancer: Final results of a large Italian bone metastases study","volume":"23","author":"Santini","year":"2012","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijsu.2015.07.706","article-title":"Risk factors for the development of metachronous bone metastasis in colorectal cancer patients after curative resection","volume":"21","author":"Sun","year":"2015","journal-title":"Int. J. Surg."},{"key":"ref_20","first-page":"5169","article-title":"A Scoring System to Predict the Development of Bone Metastasis After Radical Resection of Colorectal Cancer","volume":"37","author":"Li","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00268-015-3296-x","article-title":"The Characteristics of Bone Metastasis in Patients with Colorectal Cancer: A Long-Term Report from a Single Institution","volume":"40","author":"Baek","year":"2016","journal-title":"World J. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jbo.2017.10.003","article-title":"Retrospective study of predictors of bone metastasis in colorectal cancer patients","volume":"9","author":"Zheng","year":"2017","journal-title":"J. Bone Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1007\/BF02236213","article-title":"Skeletal metastases in colorectal carcinomas: A Saskatchewan profile","volume":"42","author":"Kanthan","year":"1999","journal-title":"Dis. Colon Rectum"},{"key":"ref_24","first-page":"161","article-title":"Morphological aspects of the rectal neovascularization in colorectal cancer\u2014Anatomical-surgical and imaging implications","volume":"57","author":"Hinganu","year":"2016","journal-title":"Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/gut.51.1.56","article-title":"Frequent loss of SMAD4\/DPC4 protein in colorectal cancers","volume":"51","author":"Salovaara","year":"2002","journal-title":"Gut"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2013.07.033","article-title":"Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis","volume":"145","author":"Itatani","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_27","first-page":"1095","article-title":"Loss of Smad4 expression predicts liver metastasis in human colorectal cancer","volume":"17","author":"Losi","year":"2007","journal-title":"Oncol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2020.05.028","article-title":"Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice","volume":"487","author":"Kiyasu","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_29","first-page":"284","article-title":"Metastatic colorectal cancer presenting with bone marrow metastasis: A case series and review of literature","volume":"7","author":"Assi","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/1097-0142(197703)39:3<1337::AID-CNCR2820390349>3.0.CO;2-X","article-title":"Frequency and significance of bone marrow involvement by metastatic solid tumors","volume":"39","author":"Anner","year":"1977","journal-title":"Cancer"},{"key":"ref_31","first-page":"e7593","article-title":"Disseminated Carcinomatosis of Bone Marrow in an African Man with Metastatic Descending Colon Carcinoma","volume":"12","author":"Chuwa","year":"2020","journal-title":"Cureus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/cam4.1056","article-title":"Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival","volume":"6","author":"Viehl","year":"2017","journal-title":"Cancer Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ctrv.2012.03.005","article-title":"Mesenchymal stem cell signaling in cancer progression","volume":"39","author":"Torsvik","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41419-019-1508-2","article-title":"Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5","volume":"10","author":"Nishikawa","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"48335","DOI":"10.18632\/oncotarget.10227","article-title":"Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation","volume":"7","author":"Tanabe","year":"2016","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccell.2016.03.005","article-title":"Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients","volume":"29","author":"Halama","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1159\/000489184","article-title":"Molecular Regulation of Bone Metastasis Pathogenesis","volume":"46","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_38","unstructured":"Gong, Z.C., Qian, J., Zhang, Y.N., Wang, W., Kang, X., Xu, W., Wu, J., and Zheng, W. (2020). Colorectal cancer cells promote osteoclastogenesis and bone destruction through regulating EGF\/ERK\/CCL3 pathway. Biosci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.abb.2014.07.011","article-title":"Bone Morphogenetic Proteins: Structure, biological function and therapeutic applications","volume":"561","author":"Carreira","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_40","first-page":"1","article-title":"BMP9 signaling in stem cell differentiation and osteogenesis","volume":"2","author":"Lamplot","year":"2013","journal-title":"Am. J. Stem Cells"},{"key":"ref_41","first-page":"428","article-title":"A Rare Colon Cancer with Ossification: Pathogenetic Analysis of Bone Formation","volume":"46","author":"Noh","year":"2016","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2015.05.025","article-title":"Bone morphogenetic protein signaling in bone homeostasis","volume":"80","author":"Hiepen","year":"2015","journal-title":"Bone"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S552","DOI":"10.4103\/2152-7806.148039","article-title":"Basic science and spine literature document bone morphogenetic protein increases cancer risk","volume":"5","author":"Epstein","year":"2014","journal-title":"Surg. Neurol. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bone.2013.08.015","article-title":"BMP9 and COX-2 form an important regulatory loop in BMP9-induced osteogenic differentiation of mesenchymal stem cells","volume":"57","author":"Wang","year":"2013","journal-title":"Bone"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Song, T., Wang, W., Wang, J., He, J., Wu, N., Tang, M., He, B., and Luo, J. (2012). P38 and ERK1\/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043383"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/labinvest.2008.98","article-title":"Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects","volume":"88","author":"Luo","year":"2008","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1158\/0008-5472.CAN-09-2912","article-title":"Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2\/Smad1\/Smad4 to promote ovarian cancer cell proliferation","volume":"69","author":"Herrera","year":"2009","journal-title":"Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/jcb.25063","article-title":"Inactivation of the phosphatidylinositol 3-kinase\/Akt pathway is involved in BMP9-mediated tumor-suppressive effects in gastric cancer cells","volume":"116","author":"Duan","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00432-011-1047-4","article-title":"BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231","volume":"137","author":"Wang","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3892\/or.2015.4407","article-title":"BMP9\/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer","volume":"35","author":"Yuan","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_52","first-page":"415","article-title":"BMP9 mediates the anticancer activity of evodiamine through HIF1alpha\/p53 in human colon cancer cells","volume":"43","author":"Li","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-018-0925-7","article-title":"Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: A genomic and transcriptomic profiling based study","volume":"17","author":"Chen","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1158\/0008-5472.CAN-12-2270","article-title":"Epithelial-to-mesenchymal transition induced by TGF-beta1 is mediated by Blimp-1-dependent repression of BMP-5","volume":"72","author":"Romagnoli","year":"2012","journal-title":"Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Sarver, A.L., French, A.J., Borralho, P.M., Thayanithy, V., Oberg, A.L., Silverstein, K.A., Morlan, B.W., Riska, S.M., Boardman, L.A., and Cunningham, J.M. (2009). Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-401"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.biopha.2018.07.050","article-title":"MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5","volume":"106","author":"Chen","year":"2018","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","first-page":"3809","article-title":"Osteoprotegerin is expressed in colon carcinoma cells","volume":"25","author":"Pettersen","year":"2005","journal-title":"Anticancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/CS20050175","article-title":"Role of osteoprotegerin (OPG) in cancer","volume":"110","author":"Holen","year":"2006","journal-title":"Clin. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1158\/1078-0432.CCR-07-5019","article-title":"OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer","volume":"14","author":"Thieme","year":"2008","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000487101","article-title":"Correlation Between Baseline Osteoprotegerin Serum Levels and Prognosis of Advanced-Stage Colorectal Cancer Patients","volume":"45","author":"Nagel","year":"2018","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.tranon.2018.05.012","article-title":"Plasma Protein Profiling Reveal Osteoprotegerin as a Marker of Prognostic Impact for Colorectal Cancer","volume":"11","author":"Birgisson","year":"2018","journal-title":"Transl. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.ejca.2006.03.018","article-title":"The clinical trail of TRAIL","volume":"42","author":"Duiker","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/1078-0432.CCR-10-2884","article-title":"Clinical significance of osteoprotegerin expression in human colorectal cancer","volume":"17","author":"Tsukamoto","year":"2011","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"15187","DOI":"10.18632\/oncotarget.7885","article-title":"Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/10454411000110030101","article-title":"Osteopontin","volume":"11","author":"Sodek","year":"2000","journal-title":"Crit. Rev. Oral Biol. Med. Off. Publ. Am. Assoc. Oral Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1097-4644(1998)72:30\/31+<92::AID-JCB13>3.0.CO;2-A","article-title":"Osteopontin expression and function: Role in bone remodeling","volume":"72","author":"Denhardt","year":"1998","journal-title":"J. Cell. Biochem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11605-009-1035-z","article-title":"Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer","volume":"14","author":"Likui","year":"2010","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.crvi.2003.09.007","article-title":"Osteopontin identified as colon cancer tumor progression marker","volume":"326","author":"Agrawal","year":"2003","journal-title":"Comptes Rendus Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/carcin\/bgi027","article-title":"Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis","volume":"26","author":"Wai","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s11605-011-1445-6","article-title":"The potential of osteopontin as a therapeutic target for human colorectal cancer","volume":"15","author":"Likui","year":"2011","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.3748\/wjg.v20.i30.10440","article-title":"Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells","volume":"20","author":"Wu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1089\/dna.2013.2090","article-title":"The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma","volume":"32","author":"Fan","year":"2013","journal-title":"DNA Cell Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/07357907.2016.1247454","article-title":"Association of Osteopontin Gene Polymorphisms with Colorectal Cancer","volume":"35","author":"Kamal","year":"2017","journal-title":"Cancer Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"247892","DOI":"10.1155\/2015\/247892","article-title":"Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer","volume":"2015","author":"Ng","year":"2015","journal-title":"Stem Cells Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4251\/wjgo.v7.i11.271","article-title":"Autophagy in colorectal cancer: An important switch from physiology to pathology","volume":"7","author":"Burada","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1159\/000471933","article-title":"Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway","volume":"41","author":"Huang","year":"2017","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"36839","DOI":"10.1074\/jbc.M105689200","article-title":"Structural characterization of human recombinant and bone-derived bone sialoprotein. Functional implications for cell attachment and hydroxyapatite binding","volume":"276","author":"Wuttke","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_81","first-page":"4060","article-title":"Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer","volume":"7","author":"Fedarko","year":"2001","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02411252","article-title":"Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function","volume":"34","author":"Minkin","year":"1982","journal-title":"Calcif. Tissue Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1016\/S0021-9258(17)36541-9","article-title":"Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro","volume":"269","author":"Flores","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1479-5876-5-62","article-title":"Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: Relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival","volume":"5","author":"Nagorsen","year":"2007","journal-title":"J. Transl. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00418-014-1181-6","article-title":"Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer","volume":"142","author":"How","year":"2014","journal-title":"Histochem. Cell Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: A transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/ijc.27525","article-title":"Runt-related transcription factor 2 in human colon carcinoma: A potent prognostic factor associated with estrogen receptor","volume":"131","author":"Sase","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1210\/me.2010-0452","article-title":"Estrogen receptor beta induces antiinflammatory and antitumorigenic networks in colon cancer cells","volume":"25","author":"Edvardsson","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"ref_90","first-page":"449","article-title":"Effect of TGF-beta1 on Apoptosis of Colon Cancer Cells Via the ERK Signaling Pathway","volume":"24","author":"Zhao","year":"2019","journal-title":"J. BUON Off. J. Balk. Union Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/8\/2029\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:51:21Z","timestamp":1760176281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/8\/2029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":90,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["cancers12082029"],"URL":"https:\/\/doi.org\/10.3390\/cancers12082029","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]}}}